Dernières nouvelles pour Diebold Nixdorf (NYSE:DBD) Stock

Diebold Nixdorf

Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

Diebold Nixdorf's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBD#NYSE">DBD</a>) short percent of float has fallen 6.07% since its last report. The company recently reported that it has 832 thousand shares sold short, which is 4.33% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.46 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Diebold Nixdorf Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1752242430_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Diebold Nixdorf has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Diebold Nixdorf's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Diebold Nixdorf's peer group average for short interest as a percentage of float is 11.13%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

How Is The Market Feeling About Diebold Nixdorf?

News

Diebold Nixdorf Powers Kuwait International Bank's Self-Service Expansion With Advanced Interactive Teller Machines

Earnings

Earnings Misses

Diebold Nixdorf Q1 Adj. EPS $0.38 Misses $0.67 Estimate

Guidance

Diebold Nixdorf Reiterates 2025 Revenue Growth Outlook Of Flat To Up Low Single Digits

Diebold Nixdorf Q1 Sales $841.10M Miss $880.97M Estimate

ACAD

ACDC

ACRE

ACVA

ADMA

ADNT

ADTN

AIRG

ALNT

ALTG

ALTO

ALVO

AMPH

AMPL

AMRK

AMRN

AOSL

APLS

ARIS

ARMN

ASLE

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AVDX

AXON

AXTA

AZTA

BAND

BBDO

BBGI

BBSI

BGSF

Brighthouse Financial, Inc. - Common Stock

BLBD

BLMN

BLZE

BMBL

BRKR

BROS

BTMD

BXSL

BYND

CAPL

CCSI

CDLX

CENT

CENTA

CENX

CEVA

CIVI

CMTG

CNDT

COHR

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRNC

CRNT

CSGS

CSTE

CTVA

CVNA

CYRX

Earnings Scheduled For May 7, 2025

WIIM

ADEA

AEIS

AEVA

AGYS

AIOT

ALAB

ALAR

ALGM

AMPG

ARLO

ASGN

ASTI

ATOM

BASE

BBAI

BELFA

BELFB

BIGC

BLBX

BTCT

BZAI

CAMT

CCCS

CCRD

CGNX

CLMB

CMPO

COHU

CRDO

CRSR

CSIQ

CSPI

CTSH

CWAN

CXDO

DAKT

DAVA

DCBO

DGII

DIOD

DJCO

DMRC

DOCN

DOMO

EBON

EPAM

ETWO

EVCM

EVLV

EXFY

FARO

FCUV

FLEX

FSLR

GDYN

GRRR

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

IDCC

INFA

INFY

INGM

INSG

IONQ

IPGP

ITRI

JAMF

Shares of broader tech companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

DA Davidson analyst Matthew Summerville maintains Diebold Nixdorf (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBD#NYSE">DBD</a>) with a Buy and raises the price target from $65 to $80.

Price Target

Analyst Ratings

DA Davidson Maintains Buy on Diebold Nixdorf, Raises Price Target to $80

Diebold Nixdorf Reiterates 2025 Outlook And Introduces Three-Year Plan; 2027 Targets Include $3.98B-$4.08B In Revenue And $550M-$600M In Adj. EBITDA

A hotter-than-expected inflation report initially rattled markets on Wednesday morning, but investors found confidence to buy the dip, helping major indexes recover most losses by <a href="https://www.benzinga.com/government/regulations/25/02/43656846/inflation-rises-more-than-expected-in-january-chills-interest-rate-cut-hopes">midday trading in New York.</a>
The S&amp;P 500 was down 0.2%, while the Nasdaq 100 was flat, both rebounding from sharp declines following the January Consumer Price Index report. Small-cap stocks underperformed, with the Russell 2000 slipping 0.8%.
The headline CPI rose 3% year over year in January, surpassing both December's 2.9% reading and economist forecasts of 2.9%. On a monthly basis, inflation increased 0.5%, outpacing expectations of 0.3% and accelerating from December's 0.4% gain. This marked the fastest monthly inflation rate since August 2023.
Core inflation, which excludes food and energy, climbed to 3.3% year over year from 3.2% in December. On a monthly basis, core CPI increased 0.4%, exceeding estimates of 0.3% and doubling December's 0.2% rise.
Treasuries and interest rate markets reacted sharply to the inflation data. Traders scaled back expectations for Federal Reserve rate cuts, now projecting only one reduction by December 2025.
Treasury yields surged, reflecting heightened investor uncertainty. The 10-year Treasury yield jumped 10 basis points to 4.64%. The iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) fell 1%.
Despite rising Treasury yields and a stronger dollar, gold edged up 0.2% to $2,910 per ounce. Oil prices dropped 2% after reports that Donald Trump spoke with Russian President Vladimir Putin, fueling speculation about a potential ceasefire in Ukraine.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) also rebounded from earlier session losses.
<h3 class="wp-block-heading">Wednesday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,688.40</td>
<td>0.0%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,056.85</td>
<td>-0.2%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,411.00</td>
<td>-0.4%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,257.59</td>
<td>-0.8%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:45 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent020325&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)&nbsp;inched 0.2% down to $603.77.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>) was 0.4% down to $444.41.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)&nbsp;flattened at $528.09.</li>
<li>The&nbsp;iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) eased 0.8% to $224.</li>
<li>The&nbsp;Consumer Discretionary Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>) outperformed, up 0.4%; the&nbsp;Energy Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) lagged, down 1.2%.</li>
</ul>
Wednesday&#8217;s Stock Movers
<ul>
<li>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) jumped more than 4% after the electric vehicle maker tumbled 6.3% on Tuesday, reaching oversold levels and extending its losing streak to five consecutive sessions.</li>
</ul>
Stocks reacting to company earnings reports included: 
<ul>
<li>CVS Health Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>): up 15.7%</li>
<li>Super Micro Computer Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>): up 4.5%</li>
<li>Edwards Lifesciences Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EW#NYSE">EW</a>): up 5.6%</li>
<li>América Móvil, S.A.B. de C.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMX#NYSE">AMX</a>): down 1.4%</li>
<li>American International Group Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>): up 0.2%</li>
<li>Energy Transfer LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>): up 0.3%</li>
<li>Southern Copper Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCCO#NYSE">SCCO</a>): up 2.9%</li>
<li>Gilead Sciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>): up 6.8%</li>
<li>Zillow Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/Z#NASDAQ">Z</a>): down 10.2%</li>
<li>CME Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>): up 2.2%</li>
<li>Chimera Investment Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIM#NYSE">CIM</a>): down 8.9%</li>
<li>Ryder System Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/R#NYSE">R</a>): up 4.0%</li>
<li>Smurfit WestRock Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SW#NYSE">SW</a>): down 5.8%</li>
<li>Sonic Automotive Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAH#NYSE">SAH</a>): down 2.4%</li>
<li>Alkermes Plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALKS#NASDAQ">ALKS</a>): up 4.1%</li>
<li>Anavex Life Sciences Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>): up 1.0%</li>
<li>Biogen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIIB#NASDAQ">BIIB</a>): down 4.6%</li>
<li>Blackstone Mortgage Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BXMT#NYSE">BXMT</a>): up 2.8%</li>
<li>Camtek Ltd/Israel (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>): up 1.5%</li>
<li>Chefs' Warehouse Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHEF#NASDAQ">CHEF</a>): up 13.0%</li>
<li>Diebold Nixdorf Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBD#NYSE">DBD</a>): down 3.2%</li>
<li>Dominion Energy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/D#NYSE">D</a>): up 0.6%</li>
<li>Exelon Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXC#NASDAQ">EXC</a>): up 0.4%</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43663963/record-high-egg-prices-drive-inflation-higher-in-january">Record-High Egg Prices Drive Inflation Higher In January</a></li>
</ul>
Illustration created using artificial intelligence via Midjourney.

Equities

Large Cap

Commodities

Economics

Federal Reserve

Markets

Tech

ETFs

$BTC

ALKS

AVXL

BIIB

BXMT

CHEF

SPDR Dow Jones Industrial Average ETF Trust

GILD

SCCO

SMCI

iShares Trust Barclays 20+ Year Treasury Bond Fund

TSLA

Select Sector SPDR-Consumer Discretionary

Stocks Trim Losses After Hot Inflation, Bonds Remain Pressured, Tesla Rebounds: What's Driving Markets Wednesday?

Editor&#8217;s note: The headline of this story has been updated to more accurately depict Diebold Nixdorf&#8217;s earnings results.
Diebold Nixdorf Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBD#NYSE">DBD</a>) reported <a target="_blank" href="https://s27.q4cdn.com/808990265/files/doc_financials/2024/q4/PR_25-4158_Diebold-Nixdorf-Reports-2024-Fourth-Quarter-with-Strong-Full-Year-Financial-Results.pdf" rel="noreferrer noopener">fourth-quarter</a> adjusted earnings per share of 97 cents, lower than $3.02 <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43652771/diebold-nixdorf-reports-2024-fourth-quarter-with-strong-full-year-financial-results-authorizes-its" rel="noreferrer noopener">in the year-ago period.</a>
Quarterly sales were $988.90 million, down from $1.037 billion a year ago.
Diebold Nixdorf announced Wednesday that its board of directors has authorized a new share repurchase program, under which it may repurchase up to $100 million of common stock.
&#8220;Our team delivered strong financial performance in 2024, driven by our meaningful operational improvements, continued disciplined approach to capital allocation and balance sheet management, as well as strong free cash flow generation — the highest we have generated in nearly 10 years,&#8221; Octavio Marquez, Diebold Nixdorf president and CEO said.
&#8220;The progress we made enabled us to pay down $338 million of debt throughout the year and initiate a $100 million share repurchase program, underscoring our commitment to return significant value to our stockholders,&#8221; he added.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43655820/cvs-health-stock-surges-on-better-than-expected-q4-earnings-upbeat-annual-outlook" rel="noreferrer noopener">CVS Health Q4 Earnings: Revenue And EPS Beat, Same-store Prescription Volume Up 5.9%, Upbeat FY25 Outlook And More</a>
The adjusted operating margin for the fourth quarter was 7.2%, down from 8.1% a year ago. The GAAP operating margin of 4.2% fell 120 basis points compared to the fourth quarter of 2023.
The company exited the quarter with cash and equivalents worth $311.3 million and inventories worth $528.1 million. Long-term debt as of quarter end totals $927.3 million.
In 2025, the company expects flat to low single-digit revenue growth, adjusted EBITDA in the range of $470 million to $490 million, and free cash flow of $190 million to $210 million.
Outlook: Total revenue guidance expects low single-digit growth in banking and retail (constant currency), with retail picking up in the second half of 2025. There will be a 3%-4% ($115 million) negative impact from foreign exchange, and revenue is expected to be more concentrated in the second half of the year (45% in the first half, 55% in the second half).
Price Action: DBD shares are trading lower by 1.75% to $43.23 premarket at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43656605/interpublic-struggles-with-revenue-decline-in-q4-ceo-promises-business-transformation-strategies-to-cut-costs" target="_blank" rel="noreferrer noopener">Interpublic Struggles With Revenue Decline In Q4, CEO Promises Business Transformation Strategies To Cut Costs</a></li>
</ul>
Photo: Shutterstock

Movers

General

Diebold Nixdorf Q4 Earnings: Revenue And Margins Dip, Expects Negative Forex Impact in FY25, Initiates $100 Million Stock Buyback (CORRECTED)

Diebold Nixdorf Expects FY25 Revenue Growth Of Flat To Up Low Single-Digits Vs  $3.81B Est, Adj EBITDA Of $470M-$490M, Free Cash Flow Of $190M-$210M

Diebold Nixdorf (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DBD#NYSE">DBD</a>), a world leader in transforming the way people bank and shop, today reported its 2024 fourth quarter and full-year 2024 financial results and announced it has authorized a $100 million share repurchase program.

Buybacks

Diebold Nixdorf Board Approved Its First $100M Share Repurchase Program

Diebold Nixdorf Q4 2024 Adj. EPS $0.97 Down From $3.02 YoY, Sales $988.900M Down From $1.037B YoY

Comments

Diebold Nixdorf

Actualités

Dernières nouvelles pour Diebold Nixdorf (NYSE:DBD) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL